Hong Kong-listed pharmaceutical stocks mostly rose, with Beigene-B rising more than 10%.

Hong Kong pharmaceutical stocks mostly rose, with BeiGene-B up over 10%, Hengrui Medicine-B up over 7%, CanSino Biologics-B, Hisun Pharmaceutical-B, and Rongchang Biological all on the rise.